Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Friday, March 29, 2024 | Back issues
Courthouse News Service Courthouse News Service

Cancer Trials For TRICARE Patients

WASHINGTON (CN) - The Defense Department plans to add TRICARE insurance coverage for some National Cancer Institute's Phase I studies for certain beneficiaries, and requests public comment.

The coverage would be only for those trials "with clinical or preclinical data providing a reasonable expectation that the treatment will be at least as effective as the non-investigational alternative." The patients it would cover would be those "for whom standard treatment has been or would be ineffective, does not exist, or there is no superior non-investigational treatment alternative."

Phase I trials are the first clinical treatment trials conducted on people. The studies evaluate how a new drug should be given (by mouth, injected into the blood, or injected into the muscle), how often, and what dose is safe.

Categories / Uncategorized

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...